[
  {
    "role": "user",
    "content": " H√©, Bulent. Lange tijd niet gesproken, man."
  },
  {
    "role": "assistant",
    "content": "H√© Alexander. Ja, echt lang geleden. Goed je weer te horen.\nWaar zitten we in je hoofd?"
  },
  {
    "role": "user",
    "content": " Ik wil samen met jou doorheen gaan. Zeg ook een ja of nee als je het begrijpt.\n\n(Obsidian Note: benzodiazepinen en EMDR)\n# Benzodiazepines en EMDR-therapie: Huidig Onderzoek en Klinische Overwegingen\n\nVoordat we in de details duiken, suggereert het huidige onderzoek dat hoewel benzodiazepines de effici√´ntie en effectiviteit van EMDR enigszins kunnen verminderen, sommige pati√´nten nog steeds baat kunnen hebben bij EMDR tijdens het gebruik ervan. Voor angstige pati√´nten bestaan er verschillende alternatieve benaderingen, waaronder uitgebreide voorbereidingsfasen, geleidelijk opgebouwde blootstelling, of mogelijk het gebruik van niet-benzodiazepine anxiolytica, hoewel onderzoek naar deze alternatieven beperkt blijft.\n\n## Het Kruispunt van Benzodiazepines en EMDR\n\nEye Movement Desensitization and Reprocessing (EMDR)-therapie is naar voren gekomen als een effectieve behandeling voor traumagerelateerde stoornissen, met aanzienlijk bewijs dat de werkzaamheid ondersteunt. Echter, het gelijktijdig gebruik van benzodiazepines tijdens EMDR-therapie vormt een klinische uitdaging die zorgvuldige overweging vereist.\n\n## Huidige Klinische Richtlijnen\n\nDe algemene klinische consensus is dat benzodiazepines tijdens EMDR-therapie niet worden aanbevolen. Hoewel er geen definitief onderzoek is dat aantoont dat benzodiazepines de verwerking volledig blokkeren, geven klinische rapporten aan dat ze de behandelingseffectiviteit kunnen verminderen en het verwerkingsproces aanzienlijk kunnen vertragen. Deze richtlijn komt voort uit verschillende theoretische en empirische zorgen:\n\n- **Verstoring van Emotionele Verwerking**: Benzodiazepines kunnen emotionele verdoving met betrekking tot trauma bevorderen, waardoor het moeilijk wordt om de meest uitdagende aspecten van de traumatische ervaring echt te confronteren en pati√´nten mogelijk in een toestand van vermijding houden.\n    \n- **Geheugenstoornissen**: Onderzoek toont aan dat benzodiazepines het episodisch geheugen aantasten, dat verantwoordelijk is voor het herinneren van persoonlijk ervaren gebeurtenissen. Aangezien EMDR het verwerken van traumatische herinneringen omvat, kan deze beperking het therapeutische proces ondermijnen.\n    \n- **Neurobiologische Mechanismen**: Benzodiazepines versterken de effecten van GABA, de primaire remmende neurotransmitter in het centrale zenuwstelsel, wat resulteert in CNS-depressie. Dit kalmerende effect kan de neurobiologische processen die nodig zijn voor effectieve geheugenverwerking bij EMDR tegenwerken.\n    \n\n## Tegenstrijdig Bewijs\n\nOndanks deze zorgen is het onderzoeksbeeld niet volledig eenduidig:\n\n- Een studie naar benzodiazepinegebruik tijdens langdurige blootstellingstherapie (een andere maar verwante traumabehandeling) ontdekte dat pati√´nten die benzodiazepines voorgeschreven kregen geen zwakkere reacties op de therapie hadden. De auteurs concludeerden dat \"Langdurige blootstelling een voldoende robuuste behandeling is waarvan pati√´nten die benzodiazepines nemen kunnen profiteren\".\n    \n- Anekdotisch bewijs van pati√´nten suggereert dat hoewel EMDR-vooruitgang langzamer kan zijn bij het nemen van benzodiazepines, therapeutische voordelen nog steeds kunnen optreden.\n    \n\n## Benaderingen voor Angstige Pati√´nten\n\nVoor pati√´nten die te angstig zijn om EMDR zonder medicatie te ondergaan, kunnen verschillende klinische benaderingen worden overwogen:\n\n### Uitgebreide Voorbereidingsfase\n\nAls benzodiazepines niet kunnen worden vermeden tijdens EMDR, moeten clinici mogelijk meer tijd besteden aan de \"voorbereidingsfase\" (fase twee van EMDR). Deze fase richt zich op het ontwikkelen van copingvaardigheden en emotionele regulatietechnieken voordat traumatisch materiaal wordt aangepakt.\n\n### Geleidelijke Blootstellingsbenaderingen\n\nSommige therapeuten kunnen werken aan het verminderen van angst voordat ze beginnen met EMDR-verwerking. Dit kan omvatten:\n\n- Uitgebreidere oefening met alleen bilaterale stimulatie\n- Beginnen met minder stressvolle herinneringen\n- Kortere verwerkingsperioden gebruiken met frequentere pauzes\n\n### EMDR-Aanpassingen\n\nRecente innovaties in EMDR-methodologie kunnen alternatieven bieden voor angstige pati√´nten:\n\n- **EMDR 2.0**: Deze aanpassing van standaard EMDR-therapie werd ontwikkeld om effectiviteit en effici√´ntie te verbeteren. Hoewel het niet specifiek medicatiegebruik behandelt, kan de aangepaste benadering beter worden verdragen door angstige pati√´nten.\n    \n- **Flash Techniek**: Deze nieuwe PTSS-interventie wordt bestudeerd naast standaard EMDR. Het kan minder directe betrokkenheid bij traumatisch materiaal vereisen, waardoor het mogelijk beter verdraagbaar is voor angstige pati√´nten.\n    \n\n## Medicatieoverwegingen\n\n### Risico's van Benzodiazepines\n\nNaast mogelijke interferentie met EMDR brengen benzodiazepines andere belangrijke zorgen met zich mee voor traumapati√´nten:\n\n- Een uitgebreide systematische review vond dat \"benzodiazepines ineffectief zijn voor PTSS-behandeling en -preventie, en de risico's die gepaard gaan met hun gebruik neigen de potenti√´le korte-termijn voordelen te overtreffen\".\n    \n- Er is bewijs dat suggereert dat het gebruik van benzodiazepines bij pati√´nten met recent trauma het risico op het ontwikkelen van PTSS daadwerkelijk kan verhogen.\n    \n\n### Alternatieve Medicaties\n\nHoewel onderzoek dat specifiek alternatieven voor benzodiazepines tijdens EMDR behandelt beperkt is, zouden clinici kunnen overwegen:\n\n- **Niet-benzodiazepine anxiolytica**: Medicijnen zoals buspirone of bepaalde antihistaminica kunnen minder cognitieve beperking veroorzaken.\n    \n- **Kortwerkende opties**: Als een benzodiazepine noodzakelijk wordt geacht, kan het gebruik van de laagste effectieve dosis van een kortwerkend middel alleen wanneer absoluut nodig, interferentie minimaliseren.\n    \n- **Antidepressiva**: Voor angstbeheersing op lange termijn kunnen SSRI's of SNRI's de voorkeur hebben boven benzodiazepines, vooral omdat verschillende zijn goedgekeurd door de FDA voor PTSS-behandeling.\n    \n\n## Klinische Besluitvorming\n\nDe beslissing over medicatiegebruik tijdens EMDR moet uiteindelijk worden ge√Øndividualiseerd en gezamenlijk worden gemaakt door de pati√´nt, de EMDR-therapeut en de voorschrijvende clinicus. Factoren om te overwegen zijn onder andere:\n\n- De ernst van de angst- en traumasymptomen van de pati√´nt\n- De traumageschiedenis en huidige stabiliteit van de pati√´nt\n- Eerdere reactie op medicijnen en therapie\n- De specifieke benzodiazepine, de dosering en timing ten opzichte van EMDR-sessies\n- Beschikbare alternatieven voor angstbeheersing\n\n## Conclusie\n\nHoewel de algemene aanbeveling is om benzodiazepines tijdens EMDR-therapie te vermijden, is de realiteit dat sommige pati√´nten mogelijk niet in staat zijn om traumaverwerking aan te gaan zonder medicatieondersteuning. Het beperkte onderzoek suggereert dat hoewel benzodiazepines de effici√´ntie van EMDR kunnen verminderen, ze het niet noodzakelijkerwijs volledig ineffectief maken.\n\nVoor pati√´nten die te bang zijn om EMDR zonder medicatie aan te gaan, zou een evenwichtige aanpak kunnen omvatten:\n\n- Uitgebreide voorbereiding en opbouw van hulpbronnen v√≥√≥r traumaverwerking\n- Overweging van EMDR-aanpassingen zoals de Flash-techniek\n- Verkenning van niet-benzodiazepine anxiolytische opties\n- Als benzodiazepines noodzakelijk zijn, gebruik van de minimale effectieve dosis, mogelijk getimed om interferentie met verwerking te minimaliseren\n\nVerder onderzoek is duidelijk nodig naar het veilige gebruik van anxiolytische medicatie tijdens EMDR en naar het identificeren van welke alternatieven angstige pati√´nten kunnen helpen toegang te krijgen tot deze effectieve traumabehandeling met minimale interferentie in het therapeutische proces.\n\n---\n\n# En hieronder het onderzoek van OpenAI:\n\n# Anxiolytic Medications During EMDR Therapy for PTSD in Young Adults\n\nEye Movement Desensitization and Reprocessing (EMDR) is a first-line psychotherapy for post-traumatic stress disorder (PTSD). Many young adult patients with PTSD also take anxiolytic medications. This raises the question: do these drugs interfere with, enhance, or have no effect on the efficacy of EMDR? Below we summarize research from the past decade on four major anxiolytic classes ‚Äì **benzodiazepines**, **SSRIs (selective serotonin reuptake inhibitors)**, **beta-blockers**, and **‚Äúatypical‚Äù anxiolytics** ‚Äì and how each may influence EMDR outcomes. We focus on PTSD (and note related anxiety disorder findings when relevant). A comparison table is provided for clarity.\n\n## Benzodiazepines: Effects on EMDR Efficacy\n\nBenzodiazepines (e.g. **diazepam**, **alprazolam**, **clonazepam**) are fast-acting anxiolytics that reduce anxiety and induce sedation. However, **research and clinical guidelines increasingly caution against benzodiazepine use in PTSD, especially during trauma-focused therapies like EMDR**. Key findings include:\n\n- **Lack of benefit in PTSD:** A 2015 systematic review found **no evidence that benzodiazepines alleviate PTSD symptoms or prevent PTSD after trauma** ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=The%20authors%20found%20that%20there,to%20cope%20with%20PTSD%20symptoms)). In fact, benzodiazepine use after trauma was associated with an _increased_ risk of developing PTSD ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=The%20authors%20found%20that%20there,to%20cope%20with%20PTSD%20symptoms)). Benzos are commonly prescribed in PTSD (~30‚Äì70% of patients), yet multiple studies show **no improvement or even worsening of outcomes** with their use ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Benzodiazepine%20drugs%20are%20widely%20used,is%20published%20by%20Wolters%20Kluwer)) ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=,the%20risk%20of%20developing%20PTSD)).\n    \n- **Interference with therapeutic learning:** Benzodiazepines‚Äô side effects (sedation, **anterograde amnesia**, emotional numbing) can **impair the core mechanisms of EMDR and exposure therapy**. Trauma-focused therapy requires patients to fully engage with and process traumatic memories; **benzodiazepines may hinder this by blunting emotions and memory formation** ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy)). As one report explains, _‚Äúbenzodiazepines can impair [the therapeutic] experience by numbing emotions, decreasing learning efficiency, and inhibiting memory processing of material learned in therapy.‚Äù_ ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy)). In other words, a patient heavily sedated or amnestic from a benzodiazepine might not adequately emotionally process the trauma during EMDR.\n    \n- **Evidence of reduced long-term gains:** Some studies (including earlier ones in anxiety disorders) suggest that while benzodiazepines might not completely block immediate therapy benefits, **the gains may not hold after the medication is discontinued**. For example, patients with panic disorder who did CBT while on a benzodiazepine lost many of their improvements at follow-up after stopping the drug ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=physiological%20effects%20of%20medication%20in,planned%20decision%20to%20discontinue%20medication)). This ‚Äústate-dependent‚Äù learning implies the coping skills learned in therapy didn‚Äôt fully internalize due to the drug‚Äôs effects. By analogy, in PTSD therapy the fear extinction learning during EMDR could be weaker if done under benzodiazepine influence.\n    \n- **Guideline recommendations:** Due to these concerns, **expert guidelines consider benzodiazepines ‚Äúrelatively contraindicated‚Äù for PTSD** ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=prevent%20patients%20from%20learning%20to,cope%20with%20PTSD%20symptoms)) ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=In%20the%20meantime%2C%20based%20on,exhausted%20before%20benzodiazepines%20are%20considered)). Psychotherapy and other medications (like antidepressants or adrenergic agents) are preferred **‚Äúbefore benzodiazepines are considered‚Äù** ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=In%20the%20meantime%2C%20based%20on,exhausted%20before%20benzodiazepines%20are%20considered)). The U.S. Department of Veterans Affairs also advises against benzodiazepines in PTSD treatment in most cases. Clinically, many trauma therapists avoid initiating EMDR sessions if the patient has recently taken a high dose of a benzodiazepine, because it might ‚Äúdampen‚Äù the processing (though **no study shows complete EMDR blockade** ‚Äì the concern is more about subtle interference).\n    \n\n**Bottom line:** **Benzodiazepines are the class most likely to _interfere_ with EMDR.** They can blunt emotional engagement and memory consolidation, potentially reducing the therapy‚Äôs effectiveness ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy)). They have not demonstrated added benefit for PTSD symptoms ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=The%20authors%20found%20that%20there,to%20cope%20with%20PTSD%20symptoms)). For young adults with PTSD undergoing EMDR, clinicians usually minimize or avoid benzos to ensure the patient can fully participate in trauma processing.\n\n## SSRIs (Antidepressants): Effects on EMDR Efficacy\n\nSSRIs such as **sertraline**, **paroxetine**, **fluoxetine**, and **citalopram** are frequently used in PTSD for their anti-anxiety and anti-depressant effects. Unlike benzodiazepines, SSRIs do not cause sedation or immediate tranquilization; they work over weeks to reduce anxiety and depression. **Research generally finds that SSRIs do not hinder the efficacy of EMDR ‚Äì and they may provide complementary benefits ‚Äì though a few considerations apply.** Key points:\n\n- **Concurrent use is common:** SSRIs are first-line pharmacotherapy for PTSD (with response rates ~50‚Äì60% in clinical trials) ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=Despite%20the%20popularity%20of%20pharmacotherapy,of%20patients) ). It‚Äôs common for patients to receive **both** an SSRI and trauma-focused therapy. In one large survey of veterans with PTSD, over 37% received combined psychotherapy _and_ medication ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=commonly%20referred%20treatment%20option%20for,25) ). **No incompatibility has been observed** ‚Äì trauma therapies like EMDR are routinely and successfully delivered to patients on SSRIs.\n    \n- **No significant reduction in therapy efficacy:** Available evidence suggests SSRIs have a **neutral (or even slightly positive) effect on EMDR outcomes**. For example, a PTSD trial found that adding EMDR for patients who had not improved on 12 weeks of SSRIs led to robust symptom reductions ‚Äì **57% of those patients no longer met PTSD criteria after combined treatment** ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=This%20study%20examined%20the%20add,of%20initial%20pharmacotherapy%20for%20PTSD) ). This indicates EMDR can work well in patients already on SSRIs, and the medication did not block therapy gains. Similarly, in panic disorder, combining an antidepressant with CBT produced outcomes _as good as_ therapy alone ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=antidepressant%20imipramine%20and%20placebo%20with,The)) (and in some cases slightly better, though not statistically different). **In short, SSRIs do not appear to undermine the efficacy of trauma-focused therapy.**\n    \n- **Potential supportive effects:** SSRIs can **reduce baseline anxiety, depression, and hyperarousal**, which may help patients engage more productively in EMDR. By stabilizing mood and sleep, SSRIs might put patients in a better state to confront traumatic memories. Some studies have compared medication vs. therapy: for instance, in an 8-week randomized trial, **EMDR therapy led to greater PTSD symptom reduction and more patients achieving remission compared to fluoxetine (an SSRI)** ([Eye movement desensitisation and reprocessing reduces PTSD ...](https://mentalhealth.bmj.com/content/ebmental/10/4/118.full.pdf#:~:text=Eye%20movement%20desensitisation%20and%20reprocessing,asymptomatic%20compared%20with%20fluoxetine)). However, both treatments did reduce symptoms, and many patients on the SSRI improved (just not as dramatically as the therapy group). This suggests SSRIs don‚Äôt prevent improvement; therapy simply works via a different mechanism that can yield deeper changes. Another review noted there‚Äôs _insufficient evidence to say whether SSRIs or trauma-focused psychotherapy is ‚Äúmore effective,‚Äù_ implying both approaches can significantly help PTSD ([Medication versus trauma-focused psychotherapy for adults with ...](https://www.sciencedirect.com/science/article/abs/pii/S0165178119308479#:~:text=Medication%20versus%20trauma,reduction%20among%20adults%20with)). In practice, **combined treatment** (SSRI + EMDR) is often used for potentially additive benefits ‚Äì e.g. medication controls general symptoms while EMDR tackles the trauma memory ‚Äì though research on combination vs single-modality outcomes is still evolving.\n    \n- **Emotional blunting consideration:** A small caveat with SSRIs is the side effect of **‚Äúemotional blunting‚Äù or numbness** reported by some patients ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=antidepressants%20on%20emotions%20and%20cognitions,few%20qualitative%20surveys%20of%20patients%E2%80%99)). High serotonin levels can, in certain individuals, dampen the intensity of emotions (positive and negative). A patient who feels emotionally flat or apathetic might find it harder to access deep feelings during EMDR sessions. This effect isn‚Äôt universal ‚Äì many people on SSRIs can still experience emotions ‚Äì but it is noted anecdotally (and in patient surveys ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=antidepressants%20on%20emotions%20and%20cognitions,few%20qualitative%20surveys%20of%20patients%E2%80%99))). Clinicians watch for this: if an SSRI makes someone so numb that they can‚Äôt connect to the trauma memory, adjustments may be needed (e.g. dose reduction or switching meds). **Importantly, most research does not show this side effect significantly impedes therapy on average**, but it‚Äôs an individualized consideration.\n    \n- **Relapse on medication discontinuation:** Another consideration (related to the benzodiazepine point above) is what happens **after** therapy if the SSRI is later discontinued. Some studies in phobias and panic indicate that if exposure therapy is done while an antidepressant is on board, a patient might relapse when the drug is removed ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=physiological%20effects%20of%20medication%20in,planned%20decision%20to%20discontinue%20medication)). The theory is, again, context-dependent learning ‚Äì the person coped well during therapy because the medication altered their physiological state; off medication, triggers feel different and old symptoms can resurface. To mitigate this, some experts suggest spacing out EMDR sessions from the timing of any future SSRI taper, or revisiting some therapy sessions after discontinuation to reinforce skills ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=physiological%20effects%20of%20medication%20in,planned%20decision%20to%20discontinue%20medication)). However, in PTSD specifically, clear evidence of SSRI-related relapse of therapy gains is limited. In general, if an SSRI is helping a patient function better, that _aids_ their overall recovery process, and any decision to stop the SSRI should be done carefully (regardless of therapy).\n    \n\n**Bottom line:** **SSRIs are considered to have a neutral or slightly supportive effect on EMDR.** They do **not** have the memory-impairing drawbacks of benzodiazepines, and patients on SSRIs can engage in EMDR effectively ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=This%20study%20examined%20the%20add,of%20initial%20pharmacotherapy%20for%20PTSD) ). Many young adults with PTSD benefit from concurrent SSRI medication to manage symptoms while undergoing therapy. Vigilance is needed for any emotional numbing side effects ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=antidepressants%20on%20emotions%20and%20cognitions,few%20qualitative%20surveys%20of%20patients%E2%80%99)), but overall SSRIs _interfere_ the least with EMDR among traditional pharmacologic options, according to current evidence.\n\n## Beta-Blockers: Effects on EMDR Efficacy\n\nBeta-blockers like **propranolol** (and to a lesser extent **atenolol**, **pindolol**, etc.) are not classic anxiolytics for daily use, but they are sometimes used in PTSD treatment and research. **Propranolol**, which blocks norepinephrine (adrenaline) receptors, has been investigated as an adjunct to therapy because of its unique effects on **memory reconsolidation and physiological arousal**. Here‚Äôs what recent studies show about beta-blockers in the context of PTSD and EMDR:\n\n- **Physiological calming without cognitive impairment:** Beta-blockers reduce the physical symptoms of anxiety (like heart rate, blood pressure, sweat) without causing sedation or amnesia. A patient on propranolol will still have full awareness and memory of a therapy session, but may feel less of the pounding heart and adrenaline surge. This _could_ be beneficial by preventing hyperarousal from overwhelming the patient during EMDR. Unlike benzodiazepines, **beta-blockers do _not_ blunt consciousness or memory processing** in any significant way. (Propranolol does cross the blood-brain barrier, but its main action is dampening noradrenergic activation rather than sedating.) Thus, **they are generally considered _compatible_ with therapy sessions**, and no literature indicates that taking a beta-blocker interferes with the mechanics of EMDR.\n    \n- **Use in memory reconsolidation trials:** An intriguing line of research in the last 10 years has tried using propranolol to **weaken traumatic memories** by giving the drug _before_ a therapy session in which the trauma is recalled. The idea is to block adrenaline‚Äôs enhancement of emotional memory when the memory is reactivated, thereby **‚Äúerasing‚Äù or reducing the fear response** upon reconsolidation. _In practice:_ patients take propranolol ~90 minutes before briefly recalling their trauma (with or without standard EMDR or exposure techniques). Some notable findings:\n    \n    - A **2018 randomized controlled trial** (Brunet et al.) gave propranolol or placebo before weekly memory reactivation sessions for 6 weeks. **Both groups improved similarly in PTSD severity (~35‚Äì39% symptom reduction)** by the end of treatment, meaning propranolol did not outperform placebo overall ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=weeks,Repeated%20traumatic%20memory%20reactivation) ). However, in a subset of patients with very severe PTSD, the propranolol group showed continued improvement at 3-month follow-up while the placebo group‚Äôs symptoms worsened ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=decreased%20to%20similar%20extent%20in,reactivation%2C%20PTSD%20symptom%20severity%20at) ). This suggests **propranolol augmentation might provide extra long-term benefit for the most severe cases**, even though short-term outcomes were alike.\n        \n    - A **2020 systematic review** (CADTH report) covering multiple studies found that **propranolol prior to trauma memory reactivation consistently led to reduced PTSD symptom severity and reduced physiological responses during recall** ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=Based%20on%20the%20findings%20from,to%20severity%20of%20PTSD%20symptoms)). Patients on propranolol had lower heart rate, lower skin conductance, etc., indicating a calmer response when confronting their traumatic memory. Most studies in the review showed improvement in PTSD symptoms with this approach ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=Based%20on%20the%20findings%20from,to%20severity%20of%20PTSD%20symptoms)), _though one trial showed no significant difference from placebo_ (reflecting the mixed RCT result above) ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=prior%20to%20trauma%20memory%20reactivation,to%20severity%20of%20PTSD%20symptoms)).\n        \n    - Case reports and open-label studies have even reported dramatic outcomes (e.g. patients achieving remission of PTSD after a series of propranolol+reactivation sessions) ([Trauma reactivation under propranolol among traumatized Syrian ...](https://www.tandfonline.com/doi/full/10.1080/20008198.2020.1733248#:~:text=,5%29)). While these are not controlled findings, they spurred optimism that **propranolol could ‚Äúaccelerate‚Äù recovery when paired with therapy**.\n        \n- **Beta-blockers in acute therapy sessions:** Outside of formal research protocols, some clinicians have tried using a low dose of propranolol or a short-acting beta-blocker _before an EMDR or exposure therapy session_ to help extremely anxious patients get through it. There isn‚Äôt rigorous research on this practice, but conceptually, **a beta-blocker could help a patient stay grounded (physically calm) during an emotionally intense EMDR session without impairing their ability to process the memory**. Unlike anti-anxiety meds that cloud the mind, beta-blockers keep the mind clear. If a patient‚Äôs panic symptoms (racing heart, trembling) are so strong that they dissociate or cannot focus in session, a beta-blocker might reduce those symptoms enough to let the psychological work happen. Crucially, this use should be distinguished from benzodiazepines: beta-blockers _only_ address peripheral arousal, so the emotional pain is still felt and can be processed.\n    \n- **No evidence of harm to EMDR process:** The **2023 VA/DoD PTSD guidelines** note that beta-blockers have been studied as potential adjuncts, but _‚Äúavailable data do not support their use‚Äù_ as a proven treatment ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither)). The guidelines neither recommend for nor against using them, reflecting the inconclusive efficacy data ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither)). However, they do **not cite any detriment** to psychotherapy from beta-blockers ‚Äì only that there‚Äôs not enough consistent benefit to endorse them. In other words, propranolol _might or might not_ add extra improvement, but taking it is **not known to interfere with standard therapy gains**. Patients on beta-blockers for other reasons (say, blood pressure or migraines) can engage in EMDR without issue.\n    \n\n**Bottom line:** **Beta-blockers are generally _neutral to possibly supportive_ in their impact on EMDR.** They **interfere the least** in terms of cognitive/emotional processing (since they cause no sedation or memory impairment). Some experimental evidence suggests propranolol can even augment the reduction of fear when combined with therapy ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=Based%20on%20the%20findings%20from,to%20severity%20of%20PTSD%20symptoms)), though results are mixed and not yet standard practice ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=weeks,Repeated%20traumatic%20memory%20reactivation) ). For young adults with PTSD, a beta-blocker might be considered if high physiological hyperarousal is a barrier to therapy, but on the whole, beta-blockers neither significantly hinder nor magicly boost EMDR outcomes in a consistent way.\n\n## Atypical Anxiolytics: Effects on EMDR Efficacy\n\n‚ÄúAtypical‚Äù anxiolytics refers to anti-anxiety medications **outside of the traditional benzodiazepine class**. This includes agents like **buspirone** (a 5-HT‚ÇÅ‚Çê partial agonist), certain **antihistamines** (e.g. hydroxyzine), **anticonvulsants** used for anxiety (e.g. pregabalin), and other novel approaches. These drugs are generally less sedating and less habit-forming than benzodiazepines. **Direct research on their interaction with EMDR is sparse**, but their pharmacological profiles suggest **minimal interference with therapy efficacy**:\n\n- **Buspirone:** Buspirone is a non-sedating anxiolytic often used for generalized anxiety. It **does not cause significant sedation, cognitive impairment, or memory problems** ‚Äì in fact, studies show **buspirone lacks the deleterious effects on cognition that benzodiazepines have** ([Buspirone - an overview | ScienceDirect Topics](https://www.sciencedirect.com/topics/neuroscience/buspirone#:~:text=Buspirone%20,or%20cognitive%20impairment%20like%20benzodiazepines)). It relieves anxiety **‚Äúwithout causing sedation, physical dependence, or cognitive impairment‚Äù** ([Buspirone - an overview | ScienceDirect Topics](https://www.sciencedirect.com/topics/neuroscience/buspirone#:~:text=It%20is%20effective%20in%20treating,or%20cognitive%20impairment%20like%20benzodiazepines)). Because EMDR relies on the patient‚Äôs active participation and memory processing, buspirone‚Äôs benign cognitive profile means it should not hinder the process. A patient on buspirone will be as mentally clear during EMDR as an unmedicated patient, just potentially slightly less anxious overall. There have been small trials and case series suggesting buspirone can help PTSD symptoms (e.g. reducing intrusive thoughts and irritability), though no large RCT has confirmed its efficacy ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither)). The VA‚Äôs clinician guide notes ‚Äúsome small studies suggest benefit for adjunctive buspirone in treating PTSD‚Äù but the evidence is not strong enough to formally recommend it ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither)). **Crucially, no evidence indicates buspirone impedes therapy; if anything, it may modestly help by easing baseline anxiety.**\n    \n- **Hydroxyzine and others:** Hydroxyzine is an antihistamine with anxiolytic properties (causes drowsiness in some, but no dependency or significant cognitive side effects apart from mild sedation). It might be used short-term for anxiety or sleep in PTSD patients. While hydroxyzine can cause some sleepiness, its effects are more peripheral (dry mouth, etc.) and it doesn‚Äôt specifically block memory formation. There‚Äôs no research showing an interaction with EMDR, but clinically if a patient is overly sedated from it, the therapist might adjust timing. Generally, a low dose of hydroxyzine to ‚Äútake the edge off‚Äù anxiety is considered _less intrusive_ than a benzodiazepine would be, though ideally the patient is alert during EMDR sessions. **Other atypicals** include **pregabalin (Lyrica)** or **gabapentin**, occasionally used off-label for anxiety/PTSD. These can cause dizziness or sedation in some cases, but they work via different mechanisms (calcium channel modulation) and do not cause amnesia. Like hydroxyzine, no direct studies address their impact on therapy, but given their moderate side effect profile, any interference would likely be due to sedation if it occurs. Care would be taken to titrate these so the patient isn‚Äôt groggy in session.\n    \n- **Atypical antipsychotics (used at low doses):** In some PTSD cases, low-dose atypical antipsychotics (such as **quetiapine** or **olanzapine**) are prescribed for insomnia or severe anxiety. These drugs _are sedating_ and can dull cognition somewhat, so they might have some of the same drawbacks as benzodiazepines in terms of **dampening emotional engagement**. However, they are usually used at night for sleep, not right before a therapy session. If a patient comes into EMDR groggy from an antipsychotic, it could conceivably slow the process. That said, this situation is more about managing timing/doses than a fundamental incompatibility. (These meds are not primary anxiolytics, but we mention them since they sometimes feature in PTSD polypharmacy.) The focus for ‚Äúatypical anxiolytic‚Äù is really on agents like buspirone that specifically treat anxiety without heavy sedation.\n    \n- **Psychedelic-assisted therapy (emerging research):** Outside the traditional bounds of ‚Äúanxiolytic,‚Äù recent trials have explored **MDMA-assisted therapy** for PTSD, which has potent anxiolytic and empathogenic effects during therapy sessions. MDMA (a stimulant with prosocial effects) is being studied as a one-time or intermittent adjunct to enhance processing of trauma in therapy. Early results (e.g. _MAPS trials_) suggest MDMA _with therapy_ can dramatically reduce PTSD severity for some treatment-resistant patients ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=days%20and%20called%20for%20open,2021)) ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=research%20favouring%20use%20of%20psychedelics,2021)). While MDMA is not an everyday anxiolytic and is tightly controlled, it represents an extreme example of a drug _enhancing_ therapy by increasing emotional engagement (opposite of benzos). Other novel agents like **ketamine** and **psychedelics (psilocybin)** are also being researched for trauma treatment augmentation ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=To%20showcase%20an%20innovative%20different,treatments%20have%20failed%20to%20help)) ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=benefits%20can%20be%20rapid%3A%20%E2%80%9Csometimes,in%20traditional%20psychotherapy%E2%80%9D%2C%20Daanen%20said)), but these fall outside typical prescriptions. We note this trend to illustrate that **certain non-traditional pharmacological adjuncts might _facilitate_ processing** (though more research is needed). These are generally used in specialized sessions, not concurrent daily medications.\n    \n\n**Bottom line:** **Atypical anxiolytics (especially buspirone) are considered to have _little to no interference_ with EMDR.** They do not dampen memory or alertness, so patients can fully engage in therapy. While robust research on their combined use with EMDR is limited, **expert consensus is neutral-to-positive**: for example, current guidelines neither recommend nor discourage buspirone or beta-blockers as PTSD treatments, acknowledging a lack of harm but uncertain benefit ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither)). In practice, if a young adult finds relief from an atypical anxiolytic for general anxiety, there is no evidence that it will impede their EMDR progress. These medications are fine-tuned to reduce anxiety gently, **without the processing ‚Äúblockade‚Äù that sedatives can cause**.\n\n## Comparison of Anxiolytic Classes: Impact on EMDR Therapy\n\nThe table below summarizes how each medication class tends to affect (or not affect) EMDR efficacy, based on recent research:\n\n|Medication Class|Examples (PTSD use)|Impact on EMDR Efficacy|Key Findings / Notes|\n|---|---|---|---|\n|**Benzodiazepines**|Diazepam, Alprazolam, etc.|**Likely to Interfere** (Negative) üö´|‚Äì **May hinder trauma processing** by impairing memory and emotional engagemen ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma|\n|**SSRIs (Antidepressants)**|Sertraline, Paroxetine, Fluoxetine (often first-line PTSD meds)|**Neutral to Supportive** (Generally Positive) ‚úÖ|‚Äì **Do not impair memory/cognition**, so they don‚Äôt block EMDR processing. ‚Äì Patients on SSRIs improve with EMDR as much as those not on SSRI ([|\n\n```\n        Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC\n    ](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=This%20study%20examined%20the%20add,of%20initial%20pharmacotherapy%20for%20PTSD))„Äë. Some combined-treatment cases show excellent outcomes. <br> ‚Äì May **reduce overall anxiety/depression**, helping patients engage better. *Watch for emotional blunting* in som ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=antidepressants%20on%20emotions%20and%20cognitions,few%20qualitative%20surveys%20of%20patients%E2%80%99))„Äë. <br> ‚Äì Research: EMDR often outperforms SSRIs alone in long-term efficac ([Eye movement desensitisation and reprocessing reduces PTSD ...](https://mentalhealth.bmj.com/content/ebmental/10/4/118.full.pdf#:~:text=Eye%20movement%20desensitisation%20and%20reprocessing,asymptomatic%20compared%20with%20fluoxetine))„Äë, but SSRIs **don‚Äôt hinder** therapy gains. |\n```\n\n| **Beta-Blockers** | Propranolol (occasionally used adjunct) | **Neutral / Mixed** (No harm; possible benefit in specific uses) ü§î | ‚Äì **No sedation or amnesia**: do not impede cognitive processing during EMDR. ‚Äì **Experimental use**: Propranolol before recall can dampen physiological fear response; some studies show reduced PTSD sympto ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=Based%20on%20the%20findings%20from,to%20severity%20of%20PTSD%20symptoms))4„Äë, though RCT results are mixed (no significant overall advantage vs placeb ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=weeks,Repeated%20traumatic%20memory%20reactivation) )7„Äë. ‚Äì Likely **does not interfere** with EMDR; patients remain alert. May help extremely anxious patients stay calm enough to process. | | **Atypical Anxiolytics** | Buspirone (non-benzo anxiolytic); Hydroxyzine (antihistamine); Pregabalin (off-label) | **Neutral** (No significant interference) ‚úÖ | ‚Äì **Non-sedating or mild-sedation agents** that relieve anxiety without impairing cognition (e.g. buspirone causes *no cognitive impairment or dependenc ([Buspirone - an overview | ScienceDirect Topics](https://www.sciencedirect.com/topics/neuroscience/buspirone#:~:text=It%20is%20effective%20in%20treating,or%20cognitive%20impairment%20like%20benzodiazepines))4„Äë). ‚Äì Little direct research in EMDR, but mechanistically **unlikely to hinder therapy**. Patients can fully participate. ‚Äì Clinically used to manage anxiety _around_ therapy. Any mild sedation (e.g. with hydroxyzine) is managed by timing doses so the patient is alert in sessions. |\n\n‚Äª **Legend:** ‚úÖ = minimal or no interference; üö´ = potential interference; ü§î = uncertain or context-dependent.\n\n## Conclusion\n\nIn summary, **the class of anxiolytics that interferes the least with EMDR therapy appears to be the non-sedating agents ‚Äì SSRIs and atypical anxiolytics like buspirone ‚Äì as well as beta-blockers** (which have a neutral effect). **Benzodiazepines, on the other hand, pose the greatest risk of blunting EMDR‚Äôs effectiveness** due to their impact on memory and emotional proces ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy))578„Äë. Over the past decade, multiple reviews and guidelines have discouraged benzodiazepine use in PTSD treatment, citing lack of efficacy and potential to impede therapeutic lear ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=The%20authors%20found%20that%20there,to%20cope%20with%20PTSD%20symptoms)) ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy))578„Äë.\n\nFor young adults undergoing EMDR, the evidence suggests that being on an SSRI or similar medication **does not undermine the therapy** ‚Äì many patients benefit from combined pharmacotherapy and ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=This%20study%20examined%20the%20add,of%20initial%20pharmacotherapy%20for%20PTSD) )179„Äë. These medications can be seen as providing a more stable emotional platform from which to do the hard work of trauma processing. Beta-blockers might be an interesting tool in specific scenarios (e.g. using propranolol to target traumatic memory reconsolidation), but routine use hasn‚Äôt shown dramatically better outcomes than therapy a ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=weeks,Repeated%20traumatic%20memory%20reactivation) )237„Äë. Still, importantly, beta-blockers _don‚Äôt hurt_ the process and could be considered on a case-by-case basis for symptom management. Atypical anxiolytics, though less studied, are pharmacologically unlikely to interfere and are generally well-tolerated during therapy.\n\nUltimately, **the goal is to ensure the patient can engage emotionally and cognitively with traumatic memories during EMDR**. Medications that **dampen consciousness or memory (like benzodiazepines)** are counterproductive to this goal and thus should be minimized when trauma-focused therapy is underway. In contrast, medications that **reduce pathological anxiety while preserving clarity of mind (like SSRIs, buspirone)** can be compatible or even helpful. Each patient‚Äôs situation is unique ‚Äì some may do best with no meds during EMDR, others may need an SSRI to get symptoms under control first. Coordination between prescriber and therapist is key. The research to date leans toward a cautious but not prohibitive stance on combining meds and EMDR: except for benzos (where caution is strongly warranted), **most anxiolytic medications show neutral or positive interactions with EMDR‚Äôs efficacy**, allowing young adults with PTSD to benefit fully from this evidence-based psychotherapy.\n\n**Sources:**\n\n1. Guina, J., et al. (2015). _‚ÄúBenzodiazepines for PTSD: A Systematic Review and Meta-Analysis.‚Äù_ **Journal of Psychiatric Practice, 21**(4), 281-303. (Wolters Kluwer summary: Benzodiazepines found ineffective for PTSD, with risks outweighing bene ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Benzodiazepine%20drugs%20are%20widely%20used,is%20published%20by%20Wolters%20Kluwer)) ([Benzodiazepines Not Recommended for Patients with PTSD or Recent Trauma | Wolters Kluwer](https://www.wolterskluwer.com/en/news/benzodiazepines-not-recommended-for-patients-with-ptsd-or-recent-trauma#:~:text=Because%20benzodiazepines%20have%20ongoing%20effects,of%20material%20learned%20in%20therapy))578„Äë).\n    \n2. MPR News (2015). _‚ÄúBenzodiazepines Could Actually Hinder PTSD, Trauma Therapy.‚Äù_ (Review of evidence that benzos may prevent coping-learning due to memory eff ([Benzodiazepines Could Actually Hinder PTSD, Trauma Therapy - MPR](https://www.empr.com/home/news/benzodiazepines-could-actually-hinder-ptsd-trauma-therapy/#:~:text=The%20authors%20found%20that%20there,to%20cope%20with%20PTSD%20symptoms))144„Äë).\n    \n3. Melani, M.S. et al. (2020). _‚ÄúAbsence of definitive evidence that benzodiazepines could hinder exposure-based therapy efficacy‚Äù_. **Depression & Anxiety, 37**(12):1231-42. (Systematic review of 12 RCTs: most showed benzos did not reduce therapy efficacy in short term, but some showed relapse after discontinua ([Absence of definitive scientific evidence that benzodiazepines could hinder the efficacy of exposure-based interventions in adults with anxiety or posttraumatic stress disorders: A systematic review of randomized clinical trials - PubMed](https://pubmed.ncbi.nlm.nih.gov/33241637/#:~:text=Results%3A%20%20We%20screened%201%2C529,was%20B%20for%20both%20phases))332„Äë).\n    \n4. van der Kolk, B.A. et al. (2007). _‚ÄúA Randomized Clinical Trial of EMDR, Fluoxetine, and Pill Placebo in the Treatment of PTSD: Treatment Effects and Long-term Maintenance.‚Äù_ **Journal of Clinical Psychiatry, 68**(1), 37-46. (Found EMDR led to greater reduction in PTSD symptoms than SSRI medication at 6-month follo ([Eye movement desensitisation and reprocessing reduces PTSD ...](https://mentalhealth.bmj.com/content/ebmental/10/4/118.full.pdf#:~:text=Eye%20movement%20desensitisation%20and%20reprocessing,asymptomatic%20compared%20with%20fluoxetine))L19„Äë).\n    \n5. Kim, S.H. et al. (2018). _‚ÄúAdd-on EMDR Therapy for Adults with PTSD Who Failed to Respond to Antidepressants.‚Äù_ **J Korean Med Sci, 33**(47): e306. (Adding EMDR after 12 weeks of SSRI treatment resulted in 57% of patients losing PTSD diagn ( [Add-on Eye Movement Desensitization and Reprocessing (EMDR) Therapy for Adults with Post-traumatic Stress Disorder Who Failed to Respond to Initial Antidepressant Pharmacotherapy - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC6249165/#:~:text=This%20study%20examined%20the%20add,of%20initial%20pharmacotherapy%20for%20PTSD) )179„Äë).\n    \n6. VA/DoD Clinical Practice Guideline for PTSD (2023) ‚Äì Clinician‚Äôs Medication Guide. (Recommends SSRIs as first-line; notes no clear recommendation for or against buspirone or beta-blockers due to insufficient evid ([Clinician's Guide to Medications for PTSD - PTSD: National Center for PTSD](https://www.ptsd.va.gov/professional/treat/txessentials/clinician_guide_meds.asp#:~:text=Some%20small%20studies%20suggest%20benefit,2023%20VA%2FDoD%20CPG%20recommends%20neither))L15„Äë. Strongly cautions against benzodiazepines in PTSD).\n    \n7. CADTH (2020). _‚ÄúPropranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness.‚Äù_ (Summarizes that propranolol before memory reactivation often **decreased PTSD symptom severity and physiologic responses**, although one trial showed no difference vs pla ([Propranolol for Post-Traumatic Stress Disorder: A Review of Clinical Effectiveness - NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/NBK562942/#:~:text=Based%20on%20the%20findings%20from,to%20severity%20of%20PTSD%20symptoms))213„Äë).\n    \n8. Brunet, A. et al. (2018). _‚ÄúTraumatic memory reactivation with or without propranolol for PTSD: a randomized clinical trial.‚Äù_ **American Journal of Psychiatry, 175**(5), 427-433. (No overall difference at 6 weeks between propranolol vs placebo groups, but those with severe PTSD had better maintenance with propran ( [Traumatic memory reactivation with or without propranolol for PTSD and comorbid MD symptoms: a randomised clinical trial - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC7897457/#:~:text=weeks,Repeated%20traumatic%20memory%20reactivation) )237„Äë).\n    \n9. **Additional references:** Begum, M. (2021). _‚ÄúHelp or hindrance? Medication in therapy.‚Äù_ **EMDR Therapy Quarterly** (discusses how medications like antidepressants can contextualize learning ‚Äì e.g. higher relapse if imipramine was discontinued after ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=physiological%20effects%20of%20medication%20in,planned%20decision%20to%20discontinue%20medication))142„Äë; also emerging treatments like psychede ([Help or hindrance? Medication in therapy - EMDR Therapy Quarterly](https://etq.emdrassociation.org.uk/2021/07/01/help-or-hindrance-medication-in-therapy/#:~:text=benefits%20can%20be%20rapid%3A%20%E2%80%9Csometimes,in%20traditional%20psychotherapy%E2%80%9D%2C%20Daanen%20said))174„Äë). Buspirone cognitive effects: Stahl, S. (via ScienceDirect overview) ‚Äì buspirone is anxiolytic **without sedation or cognitive impairme ([Buspirone - an overview | ScienceDirect Topics](https://www.sciencedirect.com/topics/neuroscience/buspirone#:~:text=It%20is%20effective%20in%20treating,or%20cognitive%20impairment%20like%20benzodiazepines))L24„Äë."
  },
  {
    "role": "assistant",
    "content": "Ja. Ik begrijp het volledig.\n\nJe hebt een diepgaande synthese gemaakt van zowel klinische richtlijnen als recente onderzoeksbevindingen over het effect van anxiolytica op EMDR, met bijzondere aandacht voor benzodiazepines. Je combineert dat met een genuanceerde klinische blik op alternatieven, timing, en individuele afwegingen.\n\nWil je dat we nu samen een samenvattende conclusie formuleren? Of wil je dit verwerken in een specifieke context (bijv. een artikel, een gesprek, een therapieplan)?"
  }
]